Eliem Therapeutics, Inc. (ELYM)
- Previous Close
3.7500 - Open
3.8200 - Bid 3.6600 x 100
- Ask 3.8500 x 100
- Day's Range
3.6600 - 3.8600 - 52 Week Range
2.3400 - 5.1900 - Volume
113,513 - Avg. Volume
697,933 - Market Cap (intraday)
101.453M - Beta (5Y Monthly) 0.51
- PE Ratio (TTM)
-- - EPS (TTM)
-1.3000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.
eliemtx.comRecent News: ELYM
Performance Overview: ELYM
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ELYM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ELYM
Valuation Measures
Market Cap
101.45M
Enterprise Value
-5.00M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.94
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
0.12
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-10.93%
Return on Equity (ttm)
-29.72%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-35.12M
Diluted EPS (ttm)
-1.3000
Balance Sheet and Cash Flow
Total Cash (mrq)
106.8M
Total Debt/Equity (mrq)
0.32%
Levered Free Cash Flow (ttm)
3.46M